References
- H. Lavretsky, Complementary and alternative medicine use for treatment and prevention of late-life mood and cognitive disorders, Aging Health 5 (2009), pp. 61–78.
- N.A. Qureshi and A.M. Al-Bedah, Mood disorders and complementary and alternative medicine: A literature review, Neuropsychiatr. Dis. Treat. 9 (2013), pp. 639–658.
- A. Ganesan, The impact of natural products upon modern drug discovery, Curr. Opin. Chem. Biol. 12 (2008), pp. 306–317.
- A. Lagunin, D.S. Druzhilovsky, A.V. Rudik, D.A. Filimonov, D. Gawande, K. Suresh, R. Goel, and V.V. Poroikov, Capacities of computer evaluation of hidden potential of phytochemicals of medicinal plants of the traditional Indian Ayurvedic medicine, Biomed. Chem. 10 (2016), pp. 43–54.
- A.A. Lagunin, R.K. Goel, D.Y. Gawande, P. Pahwa, T.A. Gloriozova, A.V. Dmitriev, S.M. Ivanov, A.V. Rudik, V.I. Konova, P.V. Pogodin, D.S. Druzhilovsky, and V.V. Poroikov, Chemo- and bioinformatics resources for in silico drug discovery from medicinal plants beyond their traditional use: A critical review, Nat. Prod. Rep. 31 (2014), pp. 1585–1611.
- D. Singh, D.Y. Gawande, T. Singh, V. Poroikov, and R.K. Goel, Revealing pharmacodynamics of medicinal plants using in silico approach: A case study with wet lab validation, Comput. Biol. Med. 47 (2014), pp. 1–6.
- R.K. Goel, D. Gawande, A. Lagunin, P. Randhawa, A. Mishra, and V. Poroikov, Revealing medicinal plants that are useful for the comprehensive management of epilepsy and associated comorbidities through in silico mining of their phytochemical diversity, Planta Med. 81 (2015), pp. 495–506.
- K.M. Choudhary, A. Mishra, V.V. Poroikov, and R.K. Goel, Ameliorative effect of curcumin on seizure severity, depression like behavior, learning and memory deficit in post-pentylenetetrazole-kindled mice, Eur. J. Pharmacol. 704 (2013), pp. 33–40.
- D.Y. Gawande and R.K. Goel, Pharmacological validation of in silico guided novel nootropic potential of Achyranthes aspera L, J. Ethnopharmacol. 175 (2015), pp. 324–334.
- P. Pahwa and R.K. Goel, Asparagus adscendens root extract enhances cognition and protects against scopolamine induced amnesia: An in-silico and in-vivo studies, Chem. Biol. Interac. 260 (2016), pp. 208–218.
- S. Srivastav, P. Singh, G. Mishra, K.K. Jha, and R.L. Khosa, Achyranthes aspera-an important medicinal plant: A review, J. Nat. Prod. Plant Resour. 1 (2011), pp. 1–14.
- A. Lagunin, D. Filimonov, and V. Poroikov, Multi-targeted natural products evaluation based on biological activity prediction with PASS, Curr. Pharm. Des. 16 (2010), pp. 1703–1717.
- V. Poroikov, A. Lagunin, and D. Filimonov, PharmaExpert: Diseases, targets and ligands – three in one, in QSAR and Molecular Modelling in Rational Design of Bioactive Molecules, E.A. Sener and I. Yalcin, eds., CADD & D Society, Ankara, Turkey, 2005, pp. 514–515.
- A. Snehunsu, C. Ghosal, M. Kandwal, P.K. Yadav, B.S. Nayak, K.R. Rao, S.U. Kamath, P. Sahoo, K.K. Srinivasan, S.N. Naduvil, S. Kumar, and A. Joseph, 1-Triacontanol cerotate; isolated from Marsilea quadrifolia Linn. ameliorates reactive oxidative damage in the frontal cortex and hippocampus of chronic epileptic rats, J. Ethnopharmacol. 172 (2015), pp. 80–84.
- OECD, Guideline for testing of chemicals, guidance no. 423. Acute Oral Toxicity: Acute Toxic Class Method, OECD, Paris, France, 2001.
- R.D. Porsolt, A. Bertin, and M. Jalfre, Behavioral despair in mice: A primary screening test for antidepressants, Arch. Int. Pharmacodyn. 229 (1977), pp. 327–336.
- L. Steru, R. Chermat, B. Thierry, and P. Simon, The tail suspension test: A new method for screening antidepressants in mice, Psychopharmacology 85 (1985), pp. 367–370.
- A. Zapata, V.I. Chefer, S. Parrot, and L. Denoroy, Detection and quantification of neurotransmitters in dialysates, Curr. Protoc. Neurosci. 7 (2009), pp. 1–30.
- M. Ali, Chemical investigation of Achyranthes aspera Linn, Orient. J. Chem. 9 (1993), pp. 84–85.
- T.J. Connor, P. Kelliher, Y. Shen, A. Harkin, J.P. Kelly, and B.E. Leonard, Effect of subchronic antidepressant treatments on behavioral, neurochemical, and endocrine changes in the forced-swim test, Pharmacol. Biochem. Behav. 65 (2000), pp. 591–597.
- M.J. Detke, M. Rickels, and I. Lucki, Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants, Psychopharmacology (Berl.) 121 (1995), pp. 66–72.
- J.J. Schildkraut, E.K. Gordon, and J. Durell, Catecholamine metabolism in affective disorders. I. Normetanephrine and VMA excretion in depressed patients treated with imipramine, J. Psychiatr. Res. 3 (1965), pp. 213–228.
- A. Coppen, The biochemistry of affective disorders, Br. J. Psychiatry 113 (1967), pp. 1237–1264.
- A. Randrup, J. Munkvad, R. Fog, I. Gerlach, L. Molander, B. Kjellberg, and J. Scheel-Kriiger, Mania, depression, and brain dopamine, in Current Developments in Psychopharmacology 2, W.B. Essman and L. Valzelli, eds., Spectrum Publications, New York, 1975, pp. 206–248.
- A.S. Elhwuegi, Central monoamines and their role in major depression, Prog. Neuropsychopharmacol. Biol. Psychiatry 28 (2004), pp. 435–451.
- B. Haenisch and H. Bönisch, Depression and antidepressants: Insights from knockout of dopamine, serotonin or noradrenaline re-uptake transporters, Pharmacol. Ther. 129 (2011), pp. 352–368.
- M. Páez-Pereda, New drug targets in the signaling pathways activated by antidepressants, Prog. Neuropsychopharmacol. Biol. Psychiatry 29 (2005), pp. 1010–1016.
- Z. Chen and P. Skolnick, Triple uptake inhibitors: Therapeutic potential in depression and beyond, Expert Opin. Investig. Drugs 16 (2007), pp. 1365–1377.